Alembic Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alembic Ltd with three other companies in this sector in India: Jagsonpal Pharmaceuticals Limited (2018 sales of 1.27 billion Indian Rupees [US$18.16 million] ), Jenburkt Pharmaceuticals.Ltd (1.15 billion Indian Rupees [US$16.46 million] ), and Ambalal Sarabhai Enterprises Limited (1.26 billion Indian Rupees [US$18.03 million] ).
Sales Analysis. Alembic Ltd reported sales of 1.26 billion Indian Rupees (US$18.01 million) for the fiscal year ending March of 2018. This represents a decrease of 8.6% versus 2017, when the company's sales were 1.37 billion Indian Rupees. Contributing to the drop in overall sales was the 22.8% decline in Real Estate Business, from 679.32 million Indian Rupees to 524.60 million Indian Rupees. There were also decreases in sales in Api (down 10.1% to 606.02 million Indian Rupees) .